BioNTech SE is a life sciences company advancing mRNA and related technologies for vaccines and immune-based medicines.
R&D focus
The company develops product candidates spanning infectious disease prevention and oncology, with platform capabilities designed to generate and optimize antigen-specific immune responses.
Development and manufacturing
BioNTech pairs discovery and clinical development with regulated manufacturing and partner collaboration to move candidates from trials toward commercial supply.